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Cell Culture Technology
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Sources of cell cultures
? Mammalian cells/tissues
? Insect cells 
? Plant cells/tissues
? Fish cells 
? Hybridoma cell lines (man made)
? We could generate cell culture from any life 
forms !!!!
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Mammalian Cell Culture -
History
Explosion in cell culture due to 
disposable plastic wear, laminar 
flow cabinets etc..
1950 to 
present
Normal Cells – finite lifespanHeyflick & 
Moorhead
1961
Hela – First human tumour cell 
line, from Henrietta Lack
Cervical Cancer, most notorious 
cell line – contaminates other 
lines.
Gey1952
First rodent continuous cell line 
(rat)
Earle1943
Frog embryos in clots of frog 
lymph, survived few weeks.
Harrison1907
EventScientistDate
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Cell/tissue culture-Terminology
?The in vitro growth of cells (animal; including human) 
Mimic internal environment outside the body).
?Widely used technique in cell and molecular biology, 
genetic and toxicology.
?Cell lines: Cells grown in culture
Cell lines can be grown indefinitely.
?Static culture: cells grown on solid surface 
(mostly plastics)-anchorage dependent 
(tumour/haemopoietic) 
?Suspension culture: cells grown as suspension 
in culture media-anchorage independent (normal cells)
faam copyright (C)
Mammalian cell culture-
Types of cells that may be cultured.
various typesTumour Cells
pancreatic isletEndocrine Cells
neuronesNeural Cells
organs/skinEpithelial Cells
fibroblast/muscleConnective tissue
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Mammalian cell culture-
Types of Tissue Cultures
Tissue or outgrowth from primary explant
Broken in cell suspension by enzymatic or 
mechanical means
Primary culture is culture direct from tissue
Once subcultures, referred to as cell line
Cell Culture
Fragment of tissue (explant) cultured at 
plastic-liquid interface Cells migrate outwards
Major method of initiating cultures forming 
continuous cell lines
Primary Explant Culture
Piece of tissue cultured on grid or raft at 
liquid-gas interface Maintains tissue 
architecture 
No new growth can occur
Lasts several days to weeks.
Each experiment requires new sample
Organ Culture
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Mammalian cell lines
Fibroblast cells
Skin cells
Liver cells
Lung cells
Retina cells etc
(to make tissue 
equivalents- mortal 
cell lines recovered 
from tissue)
NSO
NS1
SP2/0-Ag14
P3-X63 Ag8.653
(protein 
production for 
therapeutic & 
diagnostic)
MRC-5, HEK, 
MDBK, LLC-MK2, 
BS-C-1, CV-1, 
AGMK, WI-38, 
Vero, Hela, 3T3-
L1
(commonly used 
for viral 
propagation in 
vaccine 
production)
BHK-21
CHO-K1
Namalwa
(therapeutic 
protein 
production)
Primary cell linesHybrid cell 
lines
Medical (cancer) 
research
Producer 
cell lines
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Hybridoma TBC3.bcl-2, 
producing mouse IgG1
BHK-21 
Hybridoma, NS0 CHO-K1
Producer cell lines (some examples)
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Chick brain cells Chick skin cells
Chick muscle cellsChick heart cells
Primary cell lines isolated from chick embryo
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Mammalian cell cultures-
properties
NUMBER DOUBLING TIMES: 18 TO 36 HOURS 
LOW CELL DENSITY 
(TYPICALLY 1 X 106 CELLS/ML 0.6 grams/Liter) 
FASTIDIOUS NUTRITIONAL REQUIREMENTS
EASE OF CONTAMINATION
LOW RATE OF GROWTH
OSMOLARITY WINDOW:- 280-350 
MILLIOSMOLE/Kg
PH RANGE: 6.5 TO 7.2 TEMPERATURE: 35 TO 
370C ± 0.20C
LACK OF PROTECTIVE CELL WALL
(ADVERSELY AFFECTED BY LIQUID SHEAR 
FORCES, GAS BUBBLES) 
SENSITIVITY TO 
ENVIRONMENT
PROTEIN40%
CARBOHYDRATE    25% 
LIPID: 20%
DNA: 2.5% 
RNA: 6.9% 
WATER: 80-85%
AVERAGE COMPOSITION
(DRY WEIGHT BASIS)
5 TO 5 MICRONSAVERAGE SIZE
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Cell Growth Characteristics-
Growth Characteristic and Productivity (IgG1)of TB/C3.pEF
Time (Hour)
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Cell Growth Kinetics
Growth rate:  dN/dt = µN
µ (typical):  0015 to 0.03/Hr
TD = 24 to 48 Hrs
Product formation rate: dp/dt =α µN  +  βN
α = growth associated
β= non growth associated
Specific product synthesis rate (qp)
Dp/Ndt = qp = α µ + β = Pg/ Cell-Day
qp (typical) = 5 to 20 Pg/Cell-Day
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Mammalian cell culture-
Nutritional requirements (COMPLEX MEDIUM)
DIALYZED FETAL CALF SERUM (5 TO 10%)Animal serum
REDUCE CONTAMINATION•Antibiotics (STREPTOMYCIN, GENTAMICIN, PENICILLIN)
GLUTAMINE (4 mM)
SERVES AS ENERGY SOURCE
INCORPORATED AS AMINO ACID 
AMINO GROUP: TRANSAMINATION
NaCl (116 mM)
MAINTAINING PROPER OSMOLARITY
GLUCOSE (5 TO 8 mM)
PARTIAL SOURCE OF ENERGY
Notable nutrients in high 
concentrations
ANIMAL CELLS UNABLE TO SYNTHESIZE AMINO ACIDS: (13 
AMINO ACIDS: 0.05 mM TO 4 mM) 
ALL VITAMINS MUST BE SUPPLEMENTED (8 VITAMINS: 0.3 
TO l1цM)
INORGANIC ION SUPPLEMENTATION (6 INORGANIC IONS: 
1.1 TO 116 mM)
CARBOHYDRATE: GLUCOSE MOST COMMON (5 TO 8 mM)
Minimal essential medium
FORMULATED PRODUCTS-ADD HORMONES AND GROWTH 
FACTORS
PROPRIOTARY FORMULATIONS
Serum free medium
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Mammalian cell culture-
Application of Cell Cultures
Cancer research-compare normal and tumour
cells
Predict chemosensitivity to cancer cells
5. Research tool
Testing drugs on cell cultures instead of 
animals
4. In vitro toxicology
Pharmaceuticals: interferons, monoclonal 
antibodies, hormones and enzymes
3. Production of cellular 
macromolecules. 
Industry is largest producer of animal cells
2. Viral Vaccine 
Production
Skin Cells – Grafting in burn treatment
Blood Cells – Transfusions/ New Veins
Glandular Tissue – Replacements
1. Cells Themselves
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New Biotech Drug and Vaccine 
Approvals/New Indication 
Approvals by Year
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List of biopharmaceutical products
(some examples)
Herceptin® (Trastuzumab)
Anti-HER2 antibody
For metastatic breast cancer in HER2 overexpressed
tumors 
Rituxan® (Rituximab)
Anti-CD20 antibody
For relapsed or refractory low-grade or follicular, 
CD20 positive, B-cell non-Hodgkin's lymphoma
Thrombolytics Activase® (Alteplase, 
recombinant)
A tissue-plasminogen activator
For acute myocardial infarction, acute ischemic 
stroke and acute massive pulmonary embolism 
Cathflo® Activase® (Alteplase)
Thrombolytic agent
For the restoration of function to central venous 
access devices as assessed by the ability to 
withdraw blood 
TNKase™ (Tenecteplase)
Single-bolus thrombolytic agent
For the treatment of acute myocardial infarction 
(AMI) 
Nutropin AQ® [somatropin (rDNA origin) 
injection] 
Liquid formulation growth hormone
For GHD in children and adults; growth failure 
associated with chronic renal insufficiency (CRI) 
prior to kidney transplantation; short stature 
associated with Turner syndrome 
Nutropin® [somatropin (rDNA origin) for 
injection] 
Growth hormone
For GHD in children and adults; growth failure 
associated with CRI prior to kidney 
transplantation; short stature associated with 
Turner syndrome 
Protropin® (somatrem for injection)
Growth hormone
For growth hormone deficiency (GHD) in children 
Pulmozyme® (dornase alfa)
Inhalation Solution
For management of cystic fibrosis (including 
patients under age 5) 
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Rationale for using mammalian cell cultures
HYBRIDOMA FOR ANTIBODY PRODUCTION
RAPID ISOLATION AND PURIFICATION FOR 
ANALYTICAL USAGE
AIDING ANALYTICAL AND PRODUCT 
PURIFICATION.
RAPID METHOD FOR EXPRESSION OF NEW
PROTEINS 
STABILITY OF EXPRESSION FOR MANUFACTURING
FDA ACCEPTANCE FOR THERAPEUTIC 
PROTEINS
GENETIC SYSTEM FOR HETEROLOGOUS 
PROTEIN
(NO OTHER CHOICE: e.g. MONOCLONAL 
ANTIBODIES)
BIOSYNTHESIS AND SECRETION OF COMPLEX
POLYPEPTIDES
PROPER DISULFIDE FORMATION
CORRECT FOLDING OF ACTIVE MOLECULE
SECRETION OF ACTIVE MOLECULE
OTHER PROTEIN PROCESSING CAPABILITIES
BIOSYNTHESIS OF CARBOHYDRATE MOITIES
(SIALIC ACID, GLUCOSAMINES, GALACTOSE)
SULFATION, PHOSPHORYLATION, ETC. 
GLYCOSYLATION ONTO PROPER SITES
POST-TRANSLATIONAL MODIFICATIONS
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Figure 1.3 : (a) 3-D structure of human IgG1 molecule (Clark, M: http://www.path.cam.ac.uk/~
mrc7/lectures/models.html) and (b) The schematic model of an IgG1 (κ) antibody molecule 
showing the basic 4-chain structure and domains (VH,CH1,Vk, Ck, CH2 and CH3). The sites 
for enzymatic cleavage (papain and pepsin) are shown. 
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Mammalian cell culture-
Advantages of tissue culture
Less cell culture required as 
directly exposed to reagents
Avoid moral, legal and ethical 
issues with animal testing
Economy
Tissue has mixture of cell types
Homogenous sample identical 
over many generations
Indefinite if stored in liquid nitrogen 
(cryo-preserved -1960C)
Sample Homogenicity
Defined physiochemical 
environment  (growth media) - pH, 
temp, O2 etcEnvironment Control
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Mammalian cell culture
Disadvantages of tissue cultures
Major consideration in toxicology and 
research
In vivo cells have 3D geometry, in vitro
have 2D
In vitro lose regulation of nervous & 
endocrine systems
Difference in vivo-in vitro
Some continuous cell lines loose 
differentiated function
Result in unstable chromosome numberDifferentation/instability
Require specialised equipment –
laminar flow cabinets, 
CO2 incubators etcFacilities
Strict aseptic conditions required
Operator requires level of skill and 
knowledgeExpertise
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Working with cell culture-
Safety
? Safe practice need to be established due to number of possible 
risks
? Biohazards need to be categorised correctly
? Risk assessment
? How the materials or equipment is used
? Who uses it
? The frequency of use
? Training
? General environmental conditions
? Handling hazardous substances, equipment and condition 
should have SOP (standard operating procedure)
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Safety regulations
? Advice that might help in complying safety regulations
? USA Dept of Health and Human Services, 1993 
? E.g: Biosafety in Microbiological and Biomedical Laboratories)
? E.g: General Laboratory Health and Safety (26 pages)
? NIOSH, CDC, OhASIS
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HHS Publication No. (CDC) 93-8395 
Biosafety in Microbiological and Biomedical 
Laboratories
U.S. Department of Health and Human Services 
Public Health Service 
Centers for Disease Control and Prevention 
and 
National Institutes of Health 
3rd Edition March 1993 
U.S. GOVERNMENT PRINTING OFFICE 
WASHINGTON: 1993
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Working with cell culture-
Equipment
Pipettes (glass or 
disposable)
Culture vessels (T-flasks)
Pipette tips
Eppendorf tubes
etc
pH meter
Cell counter
Magnetic stirrer
Fluid aspirator
Fluid despenser
Glassware washing unit
Video camera and monitor
Laminar flow cabinet
Incubator/Incubator 
(CO2)
Autoclave/steriliser
Refrigerator/freezer
Inverted microscope
Upright microscope
Purified water
(deionised double 
distilled)
Centrifuge
Liquid N2 tank
Balance
Hemocytometer
Media filter unit
consumableBeneficial/additionalEssential
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Figure 3:
Flowchart showing methods 
for obtaining each type of 
cell culture.
How to obtain cell/tissue culture
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Origin of Hybridoma cell lines
Myeloma cell types
(tumour cells)
Spleen cells
(B-lymphocytes-antibody
producing cells)
X
Hybridoma cells
Cell fusions
Light 
chain
No IgGNo IgGLight 
chain
No IgGproperties
P3-X63 Ag 
UI
P3-X63 
Ag8.653
SP2/0-
Ag14
NS1/1NSOHybridoma
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Cell banking-
Liquid Nitrogen Tank (-1960C)
Cell culture (10 6-7 cell/ml)
Cryo-preserved liquid
(DMSO or Glycerol, serum)
Deep freezing
(LN2)
NASA Bioreactor
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World Cell Culture Collection Centers
American Type Cell Collection 
http://www.atcc.org/
The European Collection of Cell Cultures 
http://www.ecacc.org.uk/
Deutsche Sammlung von Mikroorganismen und 
Zellkulturen GmbH (German Collection of 
Microorganisms and Cell Cultures) 
http://www.dsmz.de/dsmzhome.htm
Japanese Collection of Research Bioresources
(JCRB)                                          
http://cellbank.nihs.go.jp/
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Mammalian Cell culture 
systems
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Applications
? Production of various proteins
? Widely used producer cell lines and its 
products (handout 1)
? Tissue equivalents
? Organ repair/transplant
? Alternative toxicity testing 
? Cloned babies!!!!!!!
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Mammalian Cell cultivation systems
1. Batch cultures 
2. High density cultures 
3. Continuous cultures 
4. Type of bioreactors
1. stirred tank bioreactor 
2. Airlift bioreactor
3. Hollow fibre bioreactor
5. Microcarrier systems
6. microencapsulation, packed bed etc.
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Table 1. Antibody production in different bioreactor systems
(Adapted from Stoll, T., Perregaux, C., Stockar, U. V., and I. W. Marison (1995). Production of 
immunoglobulin A in different reactor configurations. Cytotechnology 17:53-63.)
180 mice
400 T-flasks 
39 days
28 days
26; 5 daysb
2
7
180
250 a
1,400 a
2,200 
42
47 
120
1,600
In vivo 
In vitro
T-flask
Stirred-tank 
bioreactor, batch
Stirred-tank 
bioreactor, fed-batch
Hollow fiber reactor
Required for the 
production of 1 g
Productivity 
mg/week
Maximum 
Concentration 
mg/l
System
faam copyright (C)
A Cell Culture Facility for Animal Cells 
Single System for Anchorage-Dependent and 
Suspension Cultures
Eg: CelliGen Plus, an all-purpose stirred-tank 
bioreactor 
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.
Stirred tank bioreactor. Pictures got from http://www.accessexcellence.org/LC/SS/ferm_graphics/reactor.html
CSTR (continuous stirred tank reactor)
faam copyright (C)
A 5 litre stirred tank 
fermenter, equipped with 3 
Rushton turbines or with 3 
Intermig impellers (B.Braun)
Lonza Biologics, Slough, UK. The 
hall containing three airlift bioreactor 
with a  a total fermentation capacity 
of 6,500 liters in a range of process 
scales from 100 to 2,000 liters. 
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Air lift fermenter
-The usual height to diameter ration is 10/1 to 40/1
-no mechanical means of agitation.
(turbulence within the culture is brought about by injection of pressurized air mainly from the bottom. 
To enable efficient circulation the design operates with loops either as external loop or as internal 
loop (so called 'draught tube').
-also known as the 'pressure cycle fermenter'.
(since the growth medium undergoes successive cycles of high and low pressure ) main disadvantage 
lies in the ascending air bubbles will  increase in size in the top area of the fermenter (due to the 
decrease in hydrostatic pressure). Since large bubbles transfer oxygen less efficient than small bubbles 
this results in the generation of a sub-optimal oxygen supply in the top area.
faam copyright (C)
TECNOMOUSE - perfusion system for the long-
term cultivation of cells The heart of TECNOMOUSE is the exchangeable CultureCassette - a 
miniature bioreactor. Ideal cultivation conditions are guaranteed by 
optimal gas supply and media utilisation. 
TECNOMOUSE is a modular design and 
comprises:
A removable, programmable control unit for ease of 
operation. A modular portable rack for up to 5 Culture 
Cassettes. A media pump. An integrated gas supply unit that 
guarantees adequate gas flow to the membranes.
SEM graph of the cross-sectional structure of annular PSf/PESf
hollow fiber. 
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NASA Bioreactor ?For growing cells in zero gravity
?A rotating chamber cells grow in 
suspension 
?Simulated zero gravity achieved 
by slowly rotating the chamber, 
altering the sedimentation vector 
continuously.
?The cells remain stationary, 
subject to zero shear force, and 
tend to form three- dimensional 
aggregates, which, reputedly, 
enhances product formation. 
?When the rotation stops, the 
aggregates sediment, and the 
medium can be replaced.
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Example of an actual Home-made 
Bioreactor Run
Cell line:
YTS 177.9.6.1 rat IgG2a anti-CD4 (DA spleen x 
Y3/Ag1.2.3 hybridoma)
NB. This is a reliably good producer by all 
methods (eg 100 micrograms/ml in roller culture)! 
Cartridge:
Initial seeding with 2x10**8 cells only - this took 
2 weeks to reach optimal production and we 
would normally use more cells. 
Medium:
Total usage over 6 weeks: 40L (cost 80 pounds) 
Harvest:
Total harvest over last 4 weeks: 2.15L (average of 
77ml/day) 
Production:
Total mAb after 50% SAS purification: 3.2 g 
(avge. of 114mg/day at greater than 1.5mg/ml)
N.B. final mAb greater than 90% pure [native 
gel]. 
Other costs:
Estimate 40 pounds per litre of harvest for cost of 
nutrition bags, FCS, filters, syringes etc. 
Total cost: 
80 pounds; consumables + 80 pounds; medium + 
12 pounds; cartridge (AltraNova 140) = 172 
pounds total (for 3.2 g)
ie. approx. 50 pounds per gm (excluding 
labour/purification/hidden and indirect costs). 
http://www.molbiol.ox.ac.uk/pathology/tig/mprod.html
Home made 
HFBR
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–Skin 
–Artificial organs
–Biomaterials
–Cartilage
–Blood substitutes
–Organs
–Vascular grafts
Research projects on the 
listed tissues. Refer handouts
Tissue cultures-organ replacement
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Tissue Equivalents-Skin cells
? Dermal equivalents
? Skin repair
? To study efficacy, metabolism and toxicity 
of drugs
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Structure of the epidermis. Cells stratify into corresponding layers 
according to differential stages of keratinocytes.
Structure of the Skin
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Classical
Removal of patient's own 
skin from donor sites for 
grafting. Accompanies 
morbidity, pain, scarring 
and sometimes 
insufficient. Skin from 
donor site has to be at 
least the same size as 
burn site.
Cultured Keratinocyte
Sheet
Large number of sheets 
can be grown from a 
small piece of patient's 
normal skin.
Autografting
Technique
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EpiDermTM Skin Model (EPI-200)
1.Type: Normal human epidermal keratinocytes
(NHEK). 
2.Genetic make-up: Single donor. 
3.Derived from: Neonatal-foreskin tissue. 
4.Alternatives: NHEK from adult breast tissue. 
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From Whole Skin to Cultured Skin: Possible 
Methods
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1. Separation of epidermis from 
dermis 
2. Isolation epidermis into single cells
using enzyme dispase and mechanical force
3. Filtering to exclude crude tissues, 
followed by centrifugation and cell
count.
4. About 1x106 cells from 1cm2
skin biopsy => 4 to 5 T-75 tissue 
culture flasks (3000-5000 times
total area expansion).
Processing of Initial Skin Biopsy into Single Cells
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Formation of skin tissue-
Detachment of Skin Graft from Culture Dish
Fully grown keratinocytes will form a transparent skin sheet in the culture dish. Using 
the enzyme dispase, the graft sheet is detached from plastic within 30-45 minutes. At this stage, a 
petrolatum guaze is used as backing dressing to support the graft and preserve the orientation. 
The graft is detached and then transferred to the operating room under sterile conditions.
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DAY-BY-DAY PROCEDURE
Day -2: Getting Prepared
Day -1: Collection of Ovaries |
Oocyte Collection | Preparation of IVF Medium
Day 0: In Vitro Fertilization
Day 1-9: Culture of Embryos
Procedures for In Vitro 
Production of Bovine 
Embryos 
R.M Rivera, J.L. Edwards, A.D. Ealy, V.M. Monterroso,
A.C. Majewski, and P.J. Hansen
Dept. of Animal Sciences, University of Florida
The procedures for in vitro production [IVP; i.e. in 
vitro maturation (IVM), in vitro fertilization (IVF), and 
in vitro culture (IVC)] of embryos described here are 
based on procedures developed in other laboratories 
at the University of Wisconsin (Parrish et al., 1986), 
University of Guelph (Xu et al., 1992), and University 
of Missouri (Hernandez-Ledezma et al., 1993). These 
procedures as used by our group have been published 
previously (Edwards et al., 1997; Paula-Lopes et al., 
1998). Keep in mind that the protocols described 
here are not fixed but rather constantly evolve as new 
developments take place. Therefore, practitioners of 
IVP will be well advised to experiment with the 
procedures used, especially after reading of 
improvements made by other laboratories. This 
protocol is organized by day of the protocol with d 0 
being the day of fertilization.
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Biomaterial-
Artery, knee cartilage replacement up for 
FDA approval (Salubria)
A unique biomaterial developed for patients needing 
artery or knee cartilage replacement. It may also be used 
to speed repair of damaged nerves in patients with spinal 
cord injuries and as the basis for an implantable drug 
delivery system. It is biocompatible with body tissue 
because of 
- its attraction to water, 
- mechanical strength can be adjusted as needed, 
- it is compliant like normal body tissue
- it is made from an organic polymer (Hydrogel), 
rather than silicone.
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Biomaterials-
Left image: fabrication of various geometric shapes of sapeptide scaffolds. (A) The tape is 
approximately 8cm long, 0.5cm wide and 0.3mm thick. (B) The rope is about 2mm in 
diameter. (C) Membrane form.
Right image: molecular models of the ionic self-complementary peptides that form 
distinct polar and nonpolar sides. These peptides undergo molecular self-assembly to 
form the nanofibers that further assemble into scaffold.
Images courtesy Nature
CAMBRIDGE, Mass. -- Researchers at the Massachusetts Institute of Technology and New York University report in the June 6 issue of the Proceedings of the National 
Academy of Sciences (PNAS) that they have made a biomaterial that supports living nerve cells.
This peptide-based scaffold, on which neurons grow fibers to 
communicate with each other and establish functional synapses, ideal 
medium for growing replacement nerve cells
The peptide scaffold structure is 
analyzed by scanning electron 
microscopy (magnification 60,000X). 
Higher magnification reveals 
interwoven sapeptide nanofibers that 
are approximately 10-20nm in 
diameter.
Image courtesy Nature 
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Cell culture-Phytochemical testing
(Dosage effects of MHCP extract on growth of TB/C3.bcl2 
cell culture)
Thank You For 
Your Kind Attention
